184 related articles for article (PubMed ID: 12680954)
21. Cytokeratin subunits of inclusion bodies in rhabdoid cells: immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma.
Shiratsuchi H; Oshiro Y; Saito T; Itakura E; Kinoshita Y; Tamiya S; Oda Y; Komiyama S; Tsuneyoshi M
Int J Surg Pathol; 2001 Jan; 9(1):37-48. PubMed ID: 11469343
[TBL] [Abstract][Full Text] [Related]
22. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
[TBL] [Abstract][Full Text] [Related]
23. Proximal-type epithelioid sarcoma--a rare, aggressive subtype of epithelioid sarcoma presenting as a recurrent perineal mass in a middle-aged male.
Rekhi B; Gorad BD; Chinoy RF
World J Surg Oncol; 2007 Mar; 5():28. PubMed ID: 17341294
[TBL] [Abstract][Full Text] [Related]
24. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic problems concerning epithelioid sarcoma--case analysis.
Maksymiuk B; Smok-Ragankiewicz A; Snietura M; Lange D; Słomian G
Pol J Pathol; 2005; 56(3):139-44. PubMed ID: 16334982
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors.
Nikitakis NG; Tosios KI; Papanikolaou VS; Rivera H; Papanicolaou SI; Ioffe OB
Mod Pathol; 2004 Apr; 17(4):407-15. PubMed ID: 14976534
[TBL] [Abstract][Full Text] [Related]
27. Vimentin-negative epithelioid sarcoma. The value of an immunohistochemical panel that includes CD34.
Arber DA; Kandalaft PL; Mehta P; Battifora H
Am J Surg Pathol; 1993 Mar; 17(3):302-7. PubMed ID: 7679559
[TBL] [Abstract][Full Text] [Related]
28. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.
Dum D; Menz A; Völkel C; De Wispelaere N; Hinsch A; Gorbokon N; Lennartz M; Luebke AM; Hube-Magg C; Kluth M; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T
Exp Mol Pathol; 2022 Jun; 126():104762. PubMed ID: 35390310
[TBL] [Abstract][Full Text] [Related]
29. Cytokeratin 7 and 20 as immunohistochemical markers in identification of primary tumors in craniospinal metastases: do they have a significant role?
Taweevisit M; Isarakul P; Chaipipat M; Keetacheeva K; Wattanasirmkit V; Shuangshoti S
Neuropathology; 2003 Dec; 23(4):271-4. PubMed ID: 14719541
[TBL] [Abstract][Full Text] [Related]
30. Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer.
Rubin BP; Skarin AT; Pisick E; Rizk M; Salgia R
Eur J Cancer Prev; 2001 Feb; 10(1):77-82. PubMed ID: 11263595
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical profiling of cytokeratin expression by endometrial stroma sarcoma.
Adegboyega PA; Qiu S
Hum Pathol; 2008 Oct; 39(10):1459-64. PubMed ID: 18619644
[TBL] [Abstract][Full Text] [Related]
32. Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility.
Kim HJ; Kim MH; Kwon J; Kim JY; Park K; Ro JY
Ann Diagn Pathol; 2012 Oct; 16(5):411-5. PubMed ID: 21724432
[TBL] [Abstract][Full Text] [Related]
33. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
34. Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract.
Cabibi D; Licata A; Barresi E; Craxì A; Aragona F
Pathol Res Pract; 2003; 199(2):65-70. PubMed ID: 12747467
[TBL] [Abstract][Full Text] [Related]
35. Expression of cytokeratins 7 and 20 in ovarian neoplasia.
Cathro HP; Stoler MH
Am J Clin Pathol; 2002 Jun; 117(6):944-51. PubMed ID: 12047147
[TBL] [Abstract][Full Text] [Related]
36. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
38. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral nerve sheath tumor.
Smith TA; Machen SK; Fisher C; Goldblum JR
Am J Clin Pathol; 1999 Nov; 112(5):641-8. PubMed ID: 10549251
[TBL] [Abstract][Full Text] [Related]
40. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
Tot T
Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]